PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer

Aims: PARK2 mutation is originally associated with the progression of Parkinson's disease. In recent years, PARK2 has been reported as a tumor suppressor gene in various cancers, including lung cancer. However, the biological functions and potential molecular mechanisms of PARK2 in non-small ce...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Oncol
Prif Awduron: Duan, Huijie, Lei, Zhong, Xu, Fei, Pan, Tao, Lu, Demin, Ding, Peili, Zhu, Chunpeng, Pan, Chi, Zhang, Suzhan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2019
Pynciau:
Oncology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716169/
https://ncbi.nlm.nih.gov/pubmed/31508359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00790
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg